3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Prostatic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Accelerated Phase
1
HTLV-I Infections
1
Down Syndrome
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Azacitidine
10
Cyclophosphamide
9
venetoclax
7
fludarabine phosphate
7
fludarabine
6
Whole-Body Irradiation
6
Biopsy
6
Tacrolimus
5
Mycophenolic Acid
5
Injections
5
Decitabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Specimen Handling
4
Peripheral Blood Stem Cell Transplantation
4
Cytarabine
4
cedazuridine
3
Stem Cell Transplantation
3
Cyclosporine
3
X-Rays
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
deltacortene
×
90 days
×
Clear all
No trials found.